Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

Strategic property basis allocation focusing on land and building depreciation enhances real estate value while maximizing tax benefits for investors.
Fund managers planning to use convertible notes as an investment strategy must also understand the tax implications. Explore the key considerations.
Management fee waivers and cashless contributions offer tax efficiencies for fund managers, but planning is essential to avoid compliance risks.
J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.
Zach Anderson and Meghan Matthews discuss how investment fund blockers help foreign and tax-exempt investors with tax obligations and fund operations.
KPMG has released their 2024 biopharma report detailing the challenges and opportunities for pharma companies moving forward into the new year.
Rising physician compensation and growing financial losses are putting health systems under pressure. Explore the 2024 trends and valuation insights.
For venture capital fund managers, understanding the Qualified Small Business Stock (QSBS) exemption presents a lucrative opportunity. Learn more in this overview.
The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.
The National Association of Manufacturers (NAM) conducted its Q3 Outlook Survey. Read more for a discussion and analysis of the results.
Investment funds face complex state compliance challenges, including withholding obligations, pass-through taxes and multistate filing requirements.
Weaver's Jeremy Winkler and Selina McUmber discuss insights and trends from the 2024 NCREIF conference on real estate, valuations and global future-shaping factors.
1 2 3 4 5 6 18